Steven A Carr. Ph.D - Brief Bio
Dr. Carr is Director of Proteomics at the Broad Institute of MIT and Harvard. He is internationally recognized as a leader in the development of novel proteomics methods and in their application in biology and medicine. Dr. Carr and his group collaborate with scientists throughout the greater Broad community (Broad Institute, Harvard, Harvard Medical School, and the 17 Harvard affiliated hospitals) to apply state-of-the art proteomics technology to address compelling questions in biology, chemistry and clinical medicine. Research in his lab focuses on detecting and quantifying posttranslational modifications (phosphorylation, acetylation, ubiquitylation, methylation, etc.) in the proteome, developing new technologies to quantify proteins in cells and biofluids with high sensitivity and specificity, improving informatics for peptide and protein assignment using MS data, and integrating MS-derived data with genomic data. The Carr group is also known for developing and applying systematic approaches for biomarker discovery and validation to ultimately provide biomarkers for cancers, heart disease, infectious diseases and metabolic disorders.
Prior to joining the Broad Institute in 2004, Dr. Carr held scientific leadership positions in the pharmaceutical and biotechnology industries as Director of Computational and Structural Sciences at GlaxoSmithKline Pharmaceuticals and Senior Director of Protein Science and Technology at Millennium Pharmaceuticals in Cambridge, MA. Dr. Carr has over 200 publications on development and use of proteomics and biological mass spectrometry. He is an associate editor of Molecular and Cellular Proteomics, and he has served on the editorial boards of Analytical Chemistry and Protein Science, among others. Dr. Carr is recipient of a number of awards including the 2011 Discovery Award in Proteomics from the Human Proteome Organization, the 2011 Thought Leader Award in Proteomics from the Agilent Foundation and the Wallace H. Coulter Lectureship Award, Pittsburgh Conference 2014.